Company: GCTS
Filing Date: 2025-05-16
Form Type: 424B5
Source: 0001104659-25-049833
Chunk: 7

Company: GCT Semiconductor Holding, Inc.
Filing Date: 2025-05-16
Form: 424B5
Chunk 7
---
| · | 26,273,653 shares of our Common Stock issuable upon exercise of outstanding warrants at a weighted-average                                  
 exercise price of $11.48 per share; and                                                                                                     |
| · | 527,397 shares of our Common Stock reserved for issuance upon the conversion of $5,273,973 aggregate principal                              
 amount of convertible notes plus the amount of accrued and unpaid interest, if any, that is payable in shares of Common Stock in connection 
 with the conversion thereof.                                                                                                                |

<div align='center'>S-4

RISK FACTORS</div>

Investing in our Securities involves substantial risk. You should carefully consider the risk factors disclosed below as well as those contained in our most recent Annual Report on Form 10-K, which is incorporated by reference herein, as updated by our subsequent filings under the Exchange Act, and the other information contained in this prospectus before acquiring any of our Common Stock. These risks could have a material adverse effect on our business, results of operations or financial condition and cause the value of our Common Stock to decline. You could lose all or part of your investment.

This prospectus supplement also contains or incorporates by reference forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of certain factors, including the risks faced by us described or incorporated by reference in this prospectus. See “Cautionary Note Regarding Forward-Looking Statements.”

<div align='center'>Risks Related to this Offering</div>

Our management will have broad discretion over the use of the proceeds we receive in this Offering and might not apply the proceeds in ways that increase the value of your investment.

Our management will have
broad discretion to use the net proceeds from this offering, including for any of the purposes described in the section entitled “Use
of Proceeds,” and you will be relying on the judgment of our management regarding the application of these proceeds. You will not
have the opportunity to influence our decisions on how to use the proceeds, and we may not apply the net proceeds of this offering in
ways that increase the value of your investment. Because of the number and variability of factors that will determine our use of the net
proceeds from this Offering, their ultimate use may vary substantially from their currently intended use. The failure by our management
to apply these funds effectively could harm our business. If we do not invest or apply the net proceeds from this offering in ways that
enhance stockholder value